The Correct Answer is D
Statement D is NOT true - pharmacological agents ARE a well-established cause of hyperprolactinemia and represent the most frequent cause of nontumoral hyperprolactinemia. 1
Analysis of Each Statement
Statement A: TRUE - Men present with reduced libido and hypogonadism
Men with hyperprolactinemia typically present with low libido and erectile dysfunction 1. The clinical manifestations in men are clearly documented, with hypogonadal symptoms being the predominant presentation.
Statement B: TRUE - Premenopausal women present with amenorrhea and galactorrhea
Women commonly develop galactorrhea and amenorrhea as presenting features of hyperprolactinemia 1. This is one of the most characteristic clinical presentations in premenopausal women.
Statement C: TRUE - Liver cirrhosis can cause hyperprolactinemia
While not extensively detailed in the provided guidelines, this is a recognized cause. The guidelines mention multiple pathological conditions that can cause hyperprolactinemia beyond prolactinomas 2, 3.
Statement D: FALSE - This is the incorrect statement
Medications are explicitly identified as "the most frequent cause of nontumoral hyperprolactinemia" 1. The evidence is overwhelming:
- 40-90% of patients on typical antipsychotics (phenothiazines, butyrophenones) develop hyperprolactinemia 1
- 50-100% of patients on risperidone develop hyperprolactinemia 1
- Metoclopramide, risperidone, and phenothiazines can cause prolactin levels exceeding 200 mg/liter 1
- Verapamil causes hyperprolactinemia in 8.5% of patients 1
- Opiates and cocaine cause mild hyperprolactinemia 1
The mechanism is dopamine antagonism at the hypothalamic-pituitary level 1.
Statement E: TRUE - Dopamine agonists are used for treatment
Dopamine agonist therapy is strongly recommended to lower prolactin levels, decrease tumor size, and restore gonadal function 1. Specifically, cabergoline is recommended over other dopamine agonists due to higher efficacy in normalizing prolactin levels (95% normalization in microadenomas, 81% in macroadenomas) and better tolerability 1.
Clinical Pitfall
The key teaching point: Always obtain a detailed medication history when evaluating hyperprolactinemia. Discontinue the offending medication for 3 days before remeasuring prolactin to confirm drug-induced etiology 1. However, never discontinue antipsychotics without consulting the prescribing psychiatrist due to risk of psychiatric decompensation 1.